Transaction #15142 · Form 4 · 0001193125-25-307215
GLOBUS MEDICAL INC · Exercise / conversion · Class A Common Stock
GLOBUS MEDICAL INC · Transacted December 1, 2025 · Filed December 3, 2025
What does this filing report?
An SEC Form 4 filing for GLOBUS MEDICAL INC records an exercise / conversion involving Class A Common Stock on December 1, 2025. The reported quantity was 5,000. The filing date is December 3, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- GLOBUS MEDICAL INC
- Company CIK
- 0001237831
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 5,000
- Reported price
- 64.44
- Reference value
- 322,200
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 13,646
- Ownership description
- Not reported
- SEC acceptance time
- Dec 3, 2025, 8:23 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Kline Kyle ↗
Senior Vice President, CFO
CIK 0002080625
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person.
- F2
- These options were granted on March 24, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
- F3
- These options were granted on February 27, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
- F4
- These options were granted on January 25, 2021 and are fully vested.
- F5
- These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.